The prognostic value of the melatonergic system-based ASMT: CYP1B1 index in solid tumors (2017)
Source: Basic & clinical pharmacology & toxicology. Conference titles: National meeting with guest society : the British pharmacology society. Unidades: FM, IB
Subjects: MELATONINA, GLÂNDULA PINEAL, GLIOMA
ABNT
KINKER, G. S et al. The prognostic value of the melatonergic system-based ASMT: CYP1B1 index in solid tumors. Basic & clinical pharmacology & toxicology. Copenhagen: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1111/bcpt.12824. Acesso em: 10 set. 2024. , 2017APA
Kinker, G. S., Ostrowski, L. H., Shinjo, S. M. O., Muxel, S. M., & Marie, S. K. N. (2017). The prognostic value of the melatonergic system-based ASMT: CYP1B1 index in solid tumors. Basic & clinical pharmacology & toxicology. Copenhagen: Faculdade de Medicina, Universidade de São Paulo. doi:10.1111/bcpt.12824NLM
Kinker GS, Ostrowski LH, Shinjo SMO, Muxel SM, Marie SKN. The prognostic value of the melatonergic system-based ASMT: CYP1B1 index in solid tumors [Internet]. Basic & clinical pharmacology & toxicology. 2017 ; 121 67.[citado 2024 set. 10 ] Available from: https://doi.org/10.1111/bcpt.12824Vancouver
Kinker GS, Ostrowski LH, Shinjo SMO, Muxel SM, Marie SKN. The prognostic value of the melatonergic system-based ASMT: CYP1B1 index in solid tumors [Internet]. Basic & clinical pharmacology & toxicology. 2017 ; 121 67.[citado 2024 set. 10 ] Available from: https://doi.org/10.1111/bcpt.12824